Published in Mayo Clin Proc on April 01, 1969
Corticosteroids: do they damage the cardiovascular system? Postgrad Med J (1994) 1.32
Biomechanical aspects of the development of aseptic necrosis of the femoral head. Arch Orthop Trauma Surg (1985) 1.15
Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis (1989) 1.10
Avascular necrosis in SLE. An apparent predilection for young patients. Ann Rheum Dis (1976) 1.09
The structure of vascular channels in the subchondral plate. J Anat (1990) 1.09
A vascular necrosis of the femoral head in childhood systemic lupus erythematosus. Can Med Assoc J (1974) 1.08
Aseptic necrosis in the femur after renal transplantation. Ann Surg (1972) 0.91
Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis (2000) 0.89
Ischaemia of bone. J Clin Pathol Suppl (R Coll Pathol) (1977) 0.86
Surgical management of complications of steroid therapy. Ann Surg (1977) 0.86
Role of plasma lipoproteins in cortisone-induced fat embolism. Am J Pathol (1972) 0.75
Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature. Pediatr Rheumatol Online J (2015) 0.75
p53 status and the efficacy of cancer therapy in vivo. Science (1994) 6.72
MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature (1998) 3.53
microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev (1994) 3.44
c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev (2000) 3.13
New histochemical method for morphologic diagnosis of early stages of myocardial ischemia. Mayo Clin Proc (1971) 2.58
Small nuclear ribonucleoprotein particle assembly in vivo: demonstration of a 6S RNA-free core precursor and posttranslational modification. Cell (1985) 2.36
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis (1983) 2.22
Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet (1982) 2.21
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Idiotype-like molecules on cells of a human T cell leukemia. J Exp Med (1983) 2.19
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med (1994) 2.11
Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11
Fracture of the Atlas: Review and Presentation of Data on Eight Cases. Ann Surg (1945) 2.04
Percutaneous central venous catheterization. Three years' experience in a neonatal intensive care unit. Am J Dis Child (1990) 1.85
atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet (1997) 1.85
Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A (2001) 1.81
Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol (1999) 1.80
Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis (1983) 1.78
Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor. Nature (1995) 1.74
Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int (1988) 1.72
Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med (1975) 1.70
Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation. Proc Natl Acad Sci U S A (1983) 1.68
Diffuse glomerulonephritis associated with infected ventriculoatrial shunt. N Engl J Med (1968) 1.67
Lumbar intraspinal extradural ganglion cyst. J Neurosurg (1968) 1.64
Corticosteroid-induced avascular necrosis. A clinical study of seventy-seven patients. J Bone Joint Surg Am (1971) 1.64
A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res (2001) 1.53
Immunologic mechanisms in systemic vasculitis. Mayo Clin Proc (1976) 1.50
Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J Biol Chem (1998) 1.47
Cytomegalovirus studies of autopsy tissue. I. Virus isolation. Am J Clin Pathol (1975) 1.47
SLE nephropathy in a patient with HIV infection: case report and review of the literature. J Rheumatol (1996) 1.46
Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell (2001) 1.45
Cytomegalovirus studies of autopsy tissue. II. Incidence of inclusion bodies and related pathologic data. Am J Clin Pathol (1975) 1.44
Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum Mol Genet (2000) 1.44
Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg (1975) 1.41
Renal biopsy in clinical practice. Mayo Clin Proc (1994) 1.39
Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol (1997) 1.38
Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med (1998) 1.35
alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem (1998) 1.34
Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am J Pathol (1999) 1.33
The progression of vesicoureteral reflux nephropathy. Ann Intern Med (1980) 1.31
Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol (2002) 1.25
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clin Infect Dis (1998) 1.24
Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus (1995) 1.24
Apoptosis and cancer drug targeting. J Clin Invest (1999) 1.22
Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone. Arch Intern Med (1982) 1.19
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 1.18
Renal involvement in relapsing polychondritis. Medicine (Baltimore) (1987) 1.16
Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis (1992) 1.16
Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Ann Intern Med (1972) 1.14
Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med (1990) 1.13
Renal failure associated with fenoprofen. Mayo Clin Proc (1980) 1.13
Pneumocystis carinii pneumonia. Can Med Assoc J (1969) 1.12
Nerve endings in the human lumbar spinal column and related structures. J Bone Joint Surg Am (1966) 1.12
Isolated renal artery dissection, presentation, evaluation, management, and pathology. Mayo Clin Proc (1982) 1.12
Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc (1969) 1.12
Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1987) 1.11
Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol (2001) 1.10
Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins. N Engl J Med (1986) 1.10
The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin Orthop Relat Res (1978) 1.09
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med (1984) 1.08
Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem (2000) 1.07
Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res (1997) 1.07
Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int (1983) 1.07
Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc (1971) 1.07
Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc (1990) 1.04
Pulse labeling of small nuclear ribonucleoproteins in vivo reveals distinct patterns of antigen recognition by human autoimmune antibodies. Proc Natl Acad Sci U S A (1984) 1.04
The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J (1996) 1.04
Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci (1991) 1.04
Swan-neck deformity following extensive cervical laminectomy. A review of twenty-one cases. J Bone Joint Surg Am (1974) 1.03
Comparative study of NZB mice under germfree and conventional conditions. J Rheumatol (1975) 1.02
Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med (1978) 1.02
A clinicopathologic study of simple unicameral bone cysts. Surg Gynecol Obstet (1968) 1.01
Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron (2001) 1.00
Time course and zonal variations of ischemia-induced myocardial cationic electrolyte derangements. Circulation (1975) 0.99
Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum (1985) 0.99
Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies. J Clin Invest (1985) 0.99
The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med (1990) 0.99
Hemangioendothelioma of the leg following metallic fixation of the tibia. Cancer (1972) 0.98
Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation. Mayo Clin Proc (1984) 0.98
p53 in life and death. Clin Cancer Res (1996) 0.98
Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis (1987) 0.97
Causes of death after renal transplantation. Arch Intern Med (1973) 0.97
T cell antiidiotypic antibodies reveal differences between two human leukemias. J Exp Med (1984) 0.97
Whipple's disease simulating sarcoidosis. A case with unique clinical and histologic features. Arch Intern Med (1972) 0.96
Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int (1974) 0.96
Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J Biol Chem (1998) 0.95
Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group. Clin Nephrol (1994) 0.94
Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats. Am J Kidney Dis (1994) 0.94
Influence of diphosphonates on progress of experimentally induced osteoporosis. J Lab Clin Med (1973) 0.93
Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J Biol Chem (1998) 0.93
Mechanisms of apoptotic cell death. Leukemia (1997) 0.93
Mechanisms of p53-mediated apoptosis. Crit Rev Oncog (1998) 0.92
IgA-IgG nephropathy: predictive indices of progressive disease. Clin Nephrol (1981) 0.92
The clinical course of idiopathic membranous nephropathy. Mayo Clin Proc (1973) 0.92
Effect of intrahepatically implanted islets of Langerhans on hepatic function in the rat. Mayo Clin Proc (1975) 0.91
Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer (1996) 0.91
Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc (1976) 0.91
The leucine zipper may induce electrophoretic mobility anomalies without DNA bending. Proc Natl Acad Sci U S A (1996) 0.91